Navigation Links
Medarex Highlights Oncology Pipeline at Needham Cancer Therapeutics Conference in New York City
Date:3/26/2009

be presented at the upcoming annual meeting of ASCO in May/June.
  • MDX-1342 is a fully human anti-CD19 antibody in Phase 1 development for chronic lymphocytic leukemia (CLL). Proof-of-concept pharmacologic Phase 1 data for CLL, as well as for rheumatoid arthritis, is expected in 2009. Initiation of the Phase 1 trial in acute lymphocytic leukemia remains on track for fourth-quarter 2009.
  • MDX-1401 is a fully human non-fucosylated anti-CD30 antibody in Phase 1 development for Hodgkin Lymphoma. Interim data from the ongoing multi-dose Phase 1 trial will be presented at the upcoming annual meeting of the American Association for Cancer Research (AACR) in April.
  • MDX-1411 is a fully human anti-CD70 antibody in Phase 1 development for clear cell renal cancer and lymphoma. Additional enrollment in the expansion cohorts is expected by the end of 2009, with interim Phase 1 data expected in early 2010.
  • MDX-1203 is the first antibody-drug conjugate generated from Medarex's Antibody-Drug Conjugate (ADC) platform to reach clinical testing. Enrollment initiation in the Phase 1 trial for renal cancer remains on track for mid-2009.
  • Additional preclinical data from Medarex's ADC platform and selected ongoing research programs will be presented at the upcoming annual meeting of AACR in April.
  • In addition to the highlighted oncology portfolio, Medarex is developing a number of promising products outside of oncology, including antibodies to IP-10 and CD19 for inflammation and antibodies for infectious diseases. Throughout this year and next, Medarex anticipates a strong flow of research and development milestones, including the goal of moving one or two more antibodies into clinical development.

    About Medarex

    Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody
    '/>"/>

    SOURCE Medarex, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine news :

    1. Medarex Announces 2008 Fourth Quarter and Year End Financial Results
    2. Medarex to Announce 2008 Fourth Quarter and Year-End Financial Results on Wednesday, February 25, 2009
    3. Medarex to Receive Milestone Payment from MedImmune for Allowance of an Investigational New Drug Application for MEDI-546
    4. Medarex Reviews Recent Highlights and Outlook for 2009
    5. Medarex to Receive Milestone Payment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis
    6. Medarex Hosts June 2nd Webcast of Ipilimumab Data Presented at ASCO
    7. Medarex Announces 2008 First Quarter Financial Results
    8. Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
    9. Medarex Announces 2007 Fourth Quarter and Year End Financial Results
    10. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
    11. Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/12/2014)... Dennis Thompson HealthDay Reporter ... way to guarantee that a surgical technique used to grind ... increase the risk of spreading cancer to other parts of ... advisory panel to the Food and Drug Administration also said ... power morcellation -- should sign a written consent stating that ...
    (Date:7/12/2014)... July 12, 2014 Demand Response Management ... considerable benefits in reducing the imbalance between energy supply ... appliances have been rolled out (due to increasing pressure ... (AMI). This helps in controlling residential appliances and thermostats ... in the North American region, and with government mandates ...
    (Date:7/12/2014)... 12, 2014 Tylenol lawsuits ( ... move forward in the federal multidistrict litigation underway ... Bernstein Liebhard LLP reports. According to a filing ... F. Stengel has ordered the deposition of a ... found that the witness’s testimony concerning the marketing ...
    (Date:7/12/2014)... SATURDAY, July 12, 2014 (HealthDay News) -- Burn injuries increase ... and outdoor grills, say burn experts. Among those most vulnerable ... among the most vulnerable and often get burned by putting ... Gamelli, director of the burn unit at Loyola University ... release. "The old adage of ,When you play with ...
    (Date:7/12/2014)... 2014 “After my mom’s stroke, she loss the ... and loss the use of his left side. Eating became a ... to help people like them enjoy eating again,” said an inventor, ... the PATRICIA CAROL HALL PLATE (P C H PLATE). , The ... ergonomic way to eat for individuals who suffer from stroke, experience ...
    Breaking Medicine News(10 mins):Health News:FDA Advisers Weigh Risks of Procedure for Removal of Uterine Fibroids 2Health News:FDA Advisers Weigh Risks of Procedure for Removal of Uterine Fibroids 3Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 4Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 4Health News:Burn Injuries More Common in Summer 2
    ... Cape Cod is synonymous with a surge of tourists, ... (Marine Biological Laboratory). For more than a century, researchers ... the world to immerse themselves in biological discovery. Many ... for study and the wealth of experts who gather ...
    ... crash data in public policy effort to boost safety , , ... the deadliest road in your town or your route to ... increase public awareness of the need to drive safely. ... in Rural Safety (CERS) developed www.saferoadmaps.org, so you can simply ...
    ... Measuring a woman,s bone mineral density can provide additional ... risk of developing breast cancer. That is the ... 1, 2008 issue of CANCER , a peer-reviewed ... suggest that incorporating bone mineral density tests with current ...
    ... TEM Counseling LLC launches new website offering convenient http://www.terrimilen.com ... clients in the comfort of their own home or office. ... ... an effort to provide clients with an alternative to traditional therapy ...
    ... following is a,transcript of the radio address by President Bush ... Congress voted to expand a,vital program that is saving lives ... also known as PEPFAR. I thank members of,Congress from both ... this important bill, and I will be honored to sign ...
    ... Mexican farm, FDA announces , , FRIDAY, July 25 ... the first big clue in the nationwide salmonella outbreak, ... had been definitively traced to a farm in Mexico. ... all-clear to jalapeno and serrano peppers grown in the ...
    Cached Medicine News:Health News:LabBits: A media tip sheet from the MBL in Woods Hole 2Health News:LabBits: A media tip sheet from the MBL in Woods Hole 3Health News:LabBits: A media tip sheet from the MBL in Woods Hole 4Health News:Researchers Map America's Deadliest Roads 2Health News:Hip bone density helps predict breast cancer risk 2Health News:Online Counseling and Life Coaching Practice Launches New Website 2Health News:Radio Address by President Bush to the Nation 2Health News:Radio Address by President Bush to the Nation 3Health News:Mexican Peppers ID'd as Salmonella Culprits 2Health News:Mexican Peppers ID'd as Salmonella Culprits 3
    (Date:7/11/2014)... , July 11, 2014 Patient engagement ... and, consequently, organizations are turning to an assortment ... As part of this evolving approach to ... educate, communicate and engage patients throughout their experiences ... patient empowerment. By mapping the patient journey and ...
    (Date:7/11/2014)... 11, 2014 According to ... Composition of Material, Application (Healthcare, Homeland security, Industrial ... (Personal Instrument, Hand-Held Instruments, Fixed, and Installed Instruments) ... 2013 - 2020", published by MarketsandMarkets, the Scintillator Market is ... from 2014 to 2020, and reach $479.16 Million ...
    (Date:7/11/2014)... , July 11, 2014 ... at 4,396.20, down 0.52%, the Dow Jones Industrial Average finished ... closed at 1,964.68, down 0.41%. The losses were broad based ... negative. The S&P 500 Health Care Sector Index ended the ... 2.75% in the last one month. Investor-Edge has initiated coverage ...
    Breaking Medicine Technology:New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Scintillator Market will be worth $479.16 Million by 2020 2Scintillator Market will be worth $479.16 Million by 2020 3Scintillator Market will be worth $479.16 Million by 2020 4Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 4
    ... Margaret A. Hamburg, M.D., said today she is revoking ... Avastin (bevacizumab) after concluding that the drug has not ... use. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Avastin will ... for certain types of colon, lung, kidney and brain ...
    ... -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED ), ... results for the second fiscal quarter ended September 30, 2011 ("2Q FY2011") ... Six M onths Ended ... Three   Months   EndedSeptember   ...
    Cached Medicine Technology:FDA Commissioner announces Avastin decision 2FDA Commissioner announces Avastin decision 3China Medical Technologies Reports Second Fiscal Quarter Financial Results 2China Medical Technologies Reports Second Fiscal Quarter Financial Results 3China Medical Technologies Reports Second Fiscal Quarter Financial Results 4China Medical Technologies Reports Second Fiscal Quarter Financial Results 5China Medical Technologies Reports Second Fiscal Quarter Financial Results 6China Medical Technologies Reports Second Fiscal Quarter Financial Results 7China Medical Technologies Reports Second Fiscal Quarter Financial Results 8China Medical Technologies Reports Second Fiscal Quarter Financial Results 9China Medical Technologies Reports Second Fiscal Quarter Financial Results 10China Medical Technologies Reports Second Fiscal Quarter Financial Results 11China Medical Technologies Reports Second Fiscal Quarter Financial Results 12China Medical Technologies Reports Second Fiscal Quarter Financial Results 13China Medical Technologies Reports Second Fiscal Quarter Financial Results 14China Medical Technologies Reports Second Fiscal Quarter Financial Results 15China Medical Technologies Reports Second Fiscal Quarter Financial Results 16China Medical Technologies Reports Second Fiscal Quarter Financial Results 17China Medical Technologies Reports Second Fiscal Quarter Financial Results 18China Medical Technologies Reports Second Fiscal Quarter Financial Results 19China Medical Technologies Reports Second Fiscal Quarter Financial Results 20China Medical Technologies Reports Second Fiscal Quarter Financial Results 21China Medical Technologies Reports Second Fiscal Quarter Financial Results 22China Medical Technologies Reports Second Fiscal Quarter Financial Results 23China Medical Technologies Reports Second Fiscal Quarter Financial Results 24
    The PC4200h is the largest capacity platelet incubator available. It features a built-in agitator with a capacity of 396 random bags (132 apheresis)....
    The PC4200i is the largest capacity platelet incubator available. It features a built-in agitator with a capacity of 396 random bags (132 apheresis)....
    ... Platelet incubators hold rotators ... Incubator temperature can be set ... from 15C to 40C (59F ... 0.5C from top to bottom. ...
    ELISA for detection of Anti-Gliadin IgA....
    Medicine Products: